Global Apomorphine Hydrochloride 麻豆原创 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR092412613

Publication Date:

September 19, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and 伪-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The global Apomorphine Hydrochloride market size was valued at US$ 298 million in 2023 and is forecast to a readjusted size of USD 386 million by 2030 with a CAGR of 3.8% during review period.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
麻豆原创 competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report is a detailed and comprehensive analysis for global Apomorphine Hydrochloride market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Apomorphine Hydrochloride market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global Apomorphine Hydrochloride market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global Apomorphine Hydrochloride market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global Apomorphine Hydrochloride market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Apomorphine Hydrochloride
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Apomorphine Hydrochloride market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma, Evolan Pharma AB (PharmSwed), Tianjin Tianwei Pharmaceutical, Sunovion, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Apomorphine Hydrochloride market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Injection
Tablets
Thinfilm
Nasal Powder (Pipeline)
麻豆原创 segment by Application
Parkinson Disease
Erectile Dysfunction
Major players covered
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Apomorphine Hydrochloride product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Apomorphine Hydrochloride, with price, sales quantity, revenue, and global market share of Apomorphine Hydrochloride from 2019 to 2024.
Chapter 3, the Apomorphine Hydrochloride competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Apomorphine Hydrochloride breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Apomorphine Hydrochloride market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Apomorphine Hydrochloride.
Chapter 14 and 15, to describe Apomorphine Hydrochloride sales channel, distributors, customers, research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Apomorphine Hydrochloride Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Injection
1.3.3 Tablets
1.3.4 Thinfilm
1.3.5 Nasal Powder (Pipeline)
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Apomorphine Hydrochloride Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Parkinson Disease
1.4.3 Erectile Dysfunction
1.5 Global Apomorphine Hydrochloride 麻豆原创 Size & Forecast
1.5.1 Global Apomorphine Hydrochloride Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Apomorphine Hydrochloride Sales Quantity (2019-2030)
1.5.3 Global Apomorphine Hydrochloride Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Supernus Pharmaceuticals
2.1.1 Supernus Pharmaceuticals Details
2.1.2 Supernus Pharmaceuticals Major Business
2.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Product and Services
2.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Supernus Pharmaceuticals Recent Developments/Updates
2.2 Britannia Pharmaceuticals STADA
2.2.1 Britannia Pharmaceuticals STADA Details
2.2.2 Britannia Pharmaceuticals STADA Major Business
2.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product and Services
2.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Britannia Pharmaceuticals STADA Recent Developments/Updates
2.3 Ever Pharma
2.3.1 Ever Pharma Details
2.3.2 Ever Pharma Major Business
2.3.3 Ever Pharma Apomorphine Hydrochloride Product and Services
2.3.4 Ever Pharma Apomorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Ever Pharma Recent Developments/Updates
2.4 Evolan Pharma AB (PharmSwed)
2.4.1 Evolan Pharma AB (PharmSwed) Details
2.4.2 Evolan Pharma AB (PharmSwed) Major Business
2.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product and Services
2.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Evolan Pharma AB (PharmSwed) Recent Developments/Updates
2.5 Tianjin Tianwei Pharmaceutical
2.5.1 Tianjin Tianwei Pharmaceutical Details
2.5.2 Tianjin Tianwei Pharmaceutical Major Business
2.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product and Services
2.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Tianjin Tianwei Pharmaceutical Recent Developments/Updates
2.6 Sunovion
2.6.1 Sunovion Details
2.6.2 Sunovion Major Business
2.6.3 Sunovion Apomorphine Hydrochloride Product and Services
2.6.4 Sunovion Apomorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Sunovion Recent Developments/Updates
3 Competitive Environment: Apomorphine Hydrochloride by Manufacturer
3.1 Global Apomorphine Hydrochloride Sales Quantity by Manufacturer (2019-2024)
3.2 Global Apomorphine Hydrochloride Revenue by Manufacturer (2019-2024)
3.3 Global Apomorphine Hydrochloride Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Apomorphine Hydrochloride by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Apomorphine Hydrochloride Manufacturer 麻豆原创 Share in 2023
3.4.3 Top 6 Apomorphine Hydrochloride Manufacturer 麻豆原创 Share in 2023
3.5 Apomorphine Hydrochloride 麻豆原创: Overall Company Footprint Analysis
3.5.1 Apomorphine Hydrochloride 麻豆原创: Region Footprint
3.5.2 Apomorphine Hydrochloride 麻豆原创: Company Product Type Footprint
3.5.3 Apomorphine Hydrochloride 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Apomorphine Hydrochloride 麻豆原创 Size by Region
4.1.1 Global Apomorphine Hydrochloride Sales Quantity by Region (2019-2030)
4.1.2 Global Apomorphine Hydrochloride Consumption Value by Region (2019-2030)
4.1.3 Global Apomorphine Hydrochloride Average Price by Region (2019-2030)
4.2 North America Apomorphine Hydrochloride Consumption Value (2019-2030)
4.3 Europe Apomorphine Hydrochloride Consumption Value (2019-2030)
4.4 Asia-Pacific Apomorphine Hydrochloride Consumption Value (2019-2030)
4.5 South America Apomorphine Hydrochloride Consumption Value (2019-2030)
4.6 Middle East & Africa Apomorphine Hydrochloride Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Apomorphine Hydrochloride Sales Quantity by Type (2019-2030)
5.2 Global Apomorphine Hydrochloride Consumption Value by Type (2019-2030)
5.3 Global Apomorphine Hydrochloride Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Apomorphine Hydrochloride Sales Quantity by Application (2019-2030)
6.2 Global Apomorphine Hydrochloride Consumption Value by Application (2019-2030)
6.3 Global Apomorphine Hydrochloride Average Price by Application (2019-2030)
7 North America
7.1 North America Apomorphine Hydrochloride Sales Quantity by Type (2019-2030)
7.2 North America Apomorphine Hydrochloride Sales Quantity by Application (2019-2030)
7.3 North America Apomorphine Hydrochloride 麻豆原创 Size by Country
7.3.1 North America Apomorphine Hydrochloride Sales Quantity by Country (2019-2030)
7.3.2 North America Apomorphine Hydrochloride Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Apomorphine Hydrochloride Sales Quantity by Type (2019-2030)
8.2 Europe Apomorphine Hydrochloride Sales Quantity by Application (2019-2030)
8.3 Europe Apomorphine Hydrochloride 麻豆原创 Size by Country
8.3.1 Europe Apomorphine Hydrochloride Sales Quantity by Country (2019-2030)
8.3.2 Europe Apomorphine Hydrochloride Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Apomorphine Hydrochloride Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Apomorphine Hydrochloride Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Apomorphine Hydrochloride 麻豆原创 Size by Region
9.3.1 Asia-Pacific Apomorphine Hydrochloride Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Apomorphine Hydrochloride Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 South Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Apomorphine Hydrochloride Sales Quantity by Type (2019-2030)
10.2 South America Apomorphine Hydrochloride Sales Quantity by Application (2019-2030)
10.3 South America Apomorphine Hydrochloride 麻豆原创 Size by Country
10.3.1 South America Apomorphine Hydrochloride Sales Quantity by Country (2019-2030)
10.3.2 South America Apomorphine Hydrochloride Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Apomorphine Hydrochloride Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Apomorphine Hydrochloride Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Apomorphine Hydrochloride 麻豆原创 Size by Country
11.3.1 Middle East & Africa Apomorphine Hydrochloride Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Apomorphine Hydrochloride Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Apomorphine Hydrochloride 麻豆原创 Drivers
12.2 Apomorphine Hydrochloride 麻豆原创 Restraints
12.3 Apomorphine Hydrochloride Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Apomorphine Hydrochloride and Key Manufacturers
13.2 Manufacturing Costs Percentage of Apomorphine Hydrochloride
13.3 Apomorphine Hydrochloride Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Apomorphine Hydrochloride Typical Distributors
14.3 Apomorphine Hydrochloride Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.